FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate (Q36644468)

From Wikidata
Jump to navigation Jump to search
scientific article published on 18 December 2012
edit
Language Label Description Also known as
English
FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate
scientific article published on 18 December 2012

    Statements

    FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate (English)
    Lin Piao
    Vaninder K Sidhu
    Yong-Hu Fang
    John J Ryan
    Kishan S Parikh
    Zhigang Hong
    Peter T Toth
    Erik Morrow
    Gary D Lopaschuk
    Stephen L Archer
    18 December 2012
    333-346

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit